speaker
Mariana
Conference Operator

Hello and welcome to Bowhead Specialty's fourth quarter 2025 earnings call. After the prepared remarks, we will hold a question and answer session. For those in the Q&A room, please use the raise hand function at the bottom of your Zoom screen to join the question queue. You can do this at any time and your questions will be addressed during the Q&A session. Also, as a reminder, this conference is being recorded. If you have any objections, please disconnect at this time. With that, I'd like to turn the call over to Shirley Yap, Head of Investor Relations. Shirley, you may begin.

speaker
Shirley Yap
Chief Accounting Officer & Head of Investor Relations

Thanks, Mariana. Good morning and welcome to Bowhead's fourth quarter 2025 earnings conference call. I'm Shirley Yap, Bowhead's chief accounting officer and head of investor relations. Joining me today are Stephen Sills, our chief executive officer, Brad Mulcahy, our chief financial officer, and Derek Broaddus, our head of casualty. As we introduced last quarter, we'll be inviting an additional member of our management team on our earnings calls to share insights from the area of expertise. Today, we are joined by Derek Braudis, who heads our casualty team. Thanks, Mariana. Good morning, and welcome to Bowhead's fourth quarter 2025 earnings conference call. Thanks, Marianna. Good morning and welcome to Bowhead's fourth quarter 2025 earnings conference call. I'm Shirley Yap, Bowhead's chief accounting officer and head of investor relations. Joining me today are Stephen Sills, our chief executive officer, Brad Mulcahy, our chief financial officer, and Derek Broaddus, our head of casualty.

speaker
Stephen Sills
Chief Executive Officer

As periods was primarily driven by our reduction and increased our seating commission.

Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-

Investor presentation